Diversified Healthcare Trust (NASDAQ:DHC) Releases Earnings Results, Beats Expectations By $0.31 EPS

Diversified Healthcare Trust (NASDAQ:DHC) announced its quarterly earnings results on Tuesday. The real estate investment trust reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.31, Zacks reports. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%.

Diversified Healthcare Trust Stock Up 1.7 %

Shares of DHC opened at $2.45 on Wednesday. The stock has a 50 day moving average price of $2.35 and a 200 day moving average price of $2.91. The company has a debt-to-equity ratio of 1.44, a quick ratio of 11.57 and a current ratio of 11.57. The stock has a market capitalization of $591.12 million, a price-to-earnings ratio of -1.52 and a beta of 2.17. Diversified Healthcare Trust has a one year low of $2.01 and a one year high of $4.24.

Diversified Healthcare Trust Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Monday, January 27th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, January 27th. Diversified Healthcare Trust’s dividend payout ratio is presently -2.48%.

Analyst Ratings Changes

Separately, StockNews.com raised shares of Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.